Page 22
Notes:
allied
academies
Curr Trend Cardiol. 2017 | Volume 1 Issue 3
September 18-19, 2017 | Toronto, Canada
Annual Conference on
HEART DISEASES
E
xtracorporeal membrane oxygenation is utilized for
providing both cardiac and respiratory support to heart
and lungs for mantainence of adequate gas exchange to
sustain life. Its main use is in children and adults with
advanced respiratory failure like hypercapnaeic respiratory
failure with an arterial pH of less than 7.20., in refractory
cardiogenic shock, advanced heart failure, cardiac arrest and
as a bridge to either cardiac transplantation or placement
of a VAD with improved survival rates in these situations.
Veno-Venous type of ECMO is used for Respiratory failure
and Veno-Arterial type of cardiac failure. In general VA
ECMO trials are shorter than V-V trials because of higher risk
of thrombus formation in the former. Major complications
of ECMO are neurological injury, life threatening bleeding,
heparin induced thrombocytopenia (HIT) and problems
during cannulation. Its relative contraindications are
conditions incompatible with normal life if the person
recovers and futility in those who are too sick.
Speaker Biography
Adarsh Kumar has been Professor & Head of cardiology department in GMC Amritsar
(India) for the last about 25 years with main field of Research in heart failure and
CAD. Has published more than 80 Research papers in different International /National
conferences all over the world. Ex President of International college of Cardiology.
Awarded gold medal for outstanding work/research in Cardiology all over the world by
Health Minister, Govt. of India.
e:
dradarshkumar1311@gmail.comRole of ECMO as advanced life care support in end stage heart disease
Adarsh Kumar
Government Medical College, India